Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01339013
Other study ID # 20110322
Secondary ID
Status Completed
Phase N/A
First received April 13, 2011
Last updated September 12, 2014
Start date April 2011
Est. completion date January 2013

Study information

Verified date September 2014
Source Region Skane
Contact n/a
Is FDA regulated No
Health authority Sweden: Medical Products Agency
Study type Interventional

Clinical Trial Summary

The anesthesia gas reflector (AnaConDa) is built on the adsorptive capacity of active carbon which also adsorbs carbon dioxide in exhaled air. Rebreathing of carbon dioxide thus occurs and must be compensated for by increased ventilation. This study aims at determining how much compensation must be given, based on the hypothesis that rebreathing depends on carbon dioxide level in blood and exhaled air.


Recruitment information / eligibility

Status Completed
Enrollment 6
Est. completion date January 2013
Est. primary completion date January 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- elective coronary artery by-pass graft surgery

- elective valve replacement surgery

- normal left ventricular ejection fraction on preoperative echocardiography

Exclusion Criteria:

- obstructive lung disease

- restrictive lung disease

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms

  • Anesthetic Ventilatory Requirements

Intervention

Device:
Anesthetic Conserving Device (AnaConDa )
Standard HME was replaced by AnaConDa. AnaConDa has charcoal filter, HME does not.

Locations

Country Name City State
Sweden University Hospital, Cardiothoracic Intensive Care Lund

Sponsors (1)

Lead Sponsor Collaborator
Region Skane

Country where clinical trial is conducted

Sweden, 

References & Publications (1)

Sturesson LW, Bodelsson M, Johansson A, Jonson B, Malmkvist G. Apparent dead space with the anesthetic conserving device, AnaConDa®: a clinical and laboratory investigation. Anesth Analg. 2013 Dec;117(6):1319-24. doi: 10.1213/ANE.0b013e3182a7778e. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Airway Dead Space With Devices for Heat and Moisture Exchange of Respiratory Gas. A conventional heat and moisture exchanger used in a respiratory circuit during anasthesia was exchanged by an AnaConDa. The AnaConDa causes re-breathing of carbon dioxide which clinically is equivalent to an increased airway dead space. The total airway dead space effect of the AnaConDa, i.e. volume of the device plus rebreathing from the charcoal filter was measured using the Single Breath Test for carbon dioxide, as was airway deadspace of the conventional Heat and Moisture Exchanger. Airway dead space differences between devices was calculated by subtraction of volumes thus achieved. Difference= Airway dead space AnaConDa - Airway dead space conventional Heat and Moisture Exchanger. 1 hour No